openPR Logo
Press release

Uveitis Industry is Expected to Reach $837 Million by 2031 - Novartis Inc., AbbVie, Johnson & Johnson Services Inc., Amgen

09-06-2024 01:24 PM CET | Health & Medicine

Press release from: DataM Intelligence 4 Market Research LLP

Uveitis Market || 2024-2031

Uveitis Market || 2024-2031

The Global Uveitis Market size was valued at US$ 456 million in 2022 and is estimated to reach US$ 837 million by 2031, growing at a CAGR of 4.8% during the forecast period (2024-2031).

Uveitis is an inflammation of the eye's middle layer, commonly affecting individuals aged 20 to 50. It can be a serious condition, potentially leading to vision loss.

Get a Free Sample Research PDF - https://www.datamintelligence.com/download-sample/uveitis-market

Market Trends:

The uveitis market is driven by technological advancements, a growing elderly population, and increased investment in research and development. Rising cases of ophthalmic disorders, such as uveitis glaucoma, and cataracts, along with improved medical infrastructure, fuel market growth. The adoption of uveitis medications, including eye drops, injections, and implants, is expanding due to government initiatives and innovative product launches. For example, Alimera Sciences received reimbursement for its ILUVIEN implant for non-infectious uveitis, contributing to the market's expansion.

Segment Covered in the Microplate Systems Market:

By Uveitis Type: Anterior Uveitis, Intermediate Uveitis, Posterior Uveitis, Pan Uveitis
By Medications: Corticosteroids, Anti-Rheumatic Drugs, Cycloplegic-Mydriatic Drugs, Immunomodulatory Therapy, Biological Therapy, Anti-Viral Drugs, Others
By Medication Form: Eye Drops, Pills, Injections, Implants), By End-User (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Regional Analysis:

The global Uveitis Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa.

The global Uveitis Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The Uveitis Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.

Major Key Players:

• Novartis AG
• AbbVie
• Johnson & Johnson Services, Inc.
• Amgen
• Alimera Sciences
• Bausch & Lomb Incorporated.
• Kiora Pharmaceuticals, Inc.
• Santen Pharmaceutical Co., Ltd.
• EyePoint Pharmaceuticals, Inc.
• Clearside Biomedical

Product Portfolio

Durezol is a topical corticosteroid used to treat pain and inflammation associated with ocular surgery and endogenous anterior uveitis.

Get Customization in the report as per your requierments: https://www.datamintelligence.com/customize/uveitis-market

Related Reports

Trauma Fixation Devices Market: https://www.datamintelligence.com/research-report/trauma-fixation-devices-market

Cardiac Ablation Devices Market: https://www.datamintelligence.com/research-report/cardiac-ablation-devices-market

Thyroid Ablation Devices Market: https://www.datamintelligence.com/research-report/thyroid-ablation-devices-market

Affiliate Marketing Request here: https://www.datamintelligence.com/affiliate-marketing

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights, and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Uveitis Industry is Expected to Reach $837 Million by 2031 - Novartis Inc., AbbVie, Johnson & Johnson Services Inc., Amgen here

News-ID: 3648004 • Views:

More Releases from DataM Intelligence 4 Market Research LLP

Japan Metagenomic Sequencing Market to hit US$ 270 Million by 2033 | Top Companies - Thermo Fisher Scientific Inc., Qiagen N.V., BGI Group
Japan Metagenomic Sequencing Market to hit US$ 270 Million by 2033 | Top Compani …
Leander, Texas and Tokyo, Japan - Dec.29.2025 As per DataM intelligence research report" Metagenomic Sequencing Market reached US$ 2.31 billion in 2024 and is expected to reach US$ 9.25 billion by 2033, growing at a CAGR of 16.7% during the forecast period 2025-2033." Microbiome research and pathogen detection needs are fueling metagenomic sequencing adoption. Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/metagenomic-sequencing-market?prasad Japan: Recent Industry Developments ✅ In December
Japan Hemp Seeds Market to hit US$ 260 Million by 2031 | Top Companies - Manitoba Harvest, Hemp Oil Canada Inc., Canah International
Japan Hemp Seeds Market to hit US$ 260 Million by 2031 | Top Companies - Manitob …
Leander, Texas and Tokyo, Japan - Dec.29.2025 As per DataM intelligence research report" Global Hemp Seeds Market reached USD 4.8 billion in 2022 and is expected to reach USD 8.7 billion by 2031 growing with a CAGR of 7.8% during the forecast period 2024-2031." Health-conscious consumers and plant-based protein demand are driving growth in hemp seeds. Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/hemp-seeds-market?prasad Japan: Recent Industry Developments ✅ In
Japan Health and Wellness Trends Accelerate Growth in the Natural Antioxidants Market | Top Companies - BASF SE, Naturex S.A, Ajinomoto Co Inc
Japan Health and Wellness Trends Accelerate Growth in the Natural Antioxidants M …
Leander, Texas and Tokyo, Japan - Dec.29.2025 As per DataM intelligence research report" Natural Antioxidants Market is estimated to reach at a high CAGR during the forecast period 2024-2031." Clean-label food and cosmetic formulations are boosting natural antioxidant adoption. Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/natural-antioxidants-market?prasad Japan: Recent Industry Developments ✅ In December 2025, Mitsubishi Corporation Life Sciences released a yeast-derived antioxidant for sauces. The ingredient prevents flavor
Japan Advanced Manufacturing and Aerospace Innovation Drive Growth in the Thermal Barrier Coatings Market | Top Companies - Praxair Surface Technologies, Metallisation Ltd., TST Engineered Coating Solutions
Japan Advanced Manufacturing and Aerospace Innovation Drive Growth in the Therma …
Leander, Texas and Tokyo, Japan - Dec.29.2025 As per DataM intelligence research report" Global Thermal Barrier Coatings market to grow at a CAGR of 4.9% during the forecast period 2024-2031." High-temperature industrial and aerospace applications are propelling thermal barrier coating demand. Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/thermal-barrier-coatings-market?prasad Japan: Recent Industry Developments ✅ In December 2025, Mitsubishi Heavy Industries (MHI) applied a new advanced TBC to its J-series

All 5 Releases


More Releases for Uveitis

Uveitis Market : An Overview Report
Introduction: Uveitis is an inflammatory condition affecting the uvea, the middle layer of the eye. It can lead to vision impairment or even blindness if left untreated. Uveitis is categorized into different types, including anterior, intermediate, posterior, and panuveitis, depending on the part of the eye affected. The condition can be caused by infections, autoimmune diseases, or trauma. With increasing cases of autoimmune disorders and infectious diseases, the prevalence of uveitis
Uveitis Treatment Market Size, Share | Trend 2030
Exclusive Report by Ameco Research: Uveitis Treatment Market Size Projected to Reach USD 2 Billion by 2030, Growing at 6% CAGR Ameco Research is proud to announce the launch of its latest market research report, Uveitis Treatment Market. This comprehensive report provides in-depth analysis and insights into the current market trends and future projections in the Industry/Market Segment. Ameco Research has been at the forefront of providing quality market research
Uveitis - Drug Pipeline Landscape, 2022
New York, Global Insight Services have recently published a report on Uveitis - Drug Pipeline Landscape. The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. Uveitis is an inflammation of the eye which damages the part of the eye called the uvea and affects other parts of the eyes which causes pain to the eyes. There are 4 types of
Uveitis - Drug Pipeline Landscape, 2022
Global Insight Services have recently published a report on Uveitis - Drug Pipeline Landscape. The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. Uveitis is an inflammation of the eye which damages the part of the eye called the uvea and affects other parts of the eyes which causes pain to the eyes. There are 4 types of uveitis based
Japan Industry Statistics of Uveitis Treatment
Global Uveitis Treatment Market: Overview Uveitis, an autoimmune eye disease, is considered rare for just around 38 in 100,000 people are afflicted by it. Because of this, it is often overlooked. Patients afflicted by uveitis are often referred to an expert after much delay on account of less awareness about the eye malady. This delays timely diagnosis and results in irreversible damage to various ocular structures. Read Report Overview: https://www.transparencymarketresearch.com/uveitis-treatment-market.html As per Cochrane,
Uveitis Treatment Market Analysis of Top industry Scenario
Global Uveitis Treatment Market report it provides a vital recent industry data which covers in general market situation along with future scenario for industry around the Globe. It also consists of major data along with forecasts of a global market along with clear presentation of diagrams (charts and tables). According to a new report published by Allied Market Research, titled, "Uveitis Treatment Market by Drug Class (Anti-inflammatory, Antimicrobial Drugs, Immunotherapy &